Search Results - "Savarino, E V"

Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria by Barbera, L, Pasta, A, Calabrese, F, Zentilin, P, Fragale, M, Barbieri, M, Peretti, G, Savarino, E V, Giannini, E G, Marabotto, E

Get full text

Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors – A cross-sectional study by Marinelli, C., Savarino, E. V., Marsilio, I., Lorenzon, G., Gavaruzzi, T., D’Incà, R., Zingone, F.

“…Inflammatory bowel diseases (IBD) are chronic relapsing disorders that have a negative impact on quality of life. They can be highly disabling and have been…”
Get full text

Invited review: Bovine colostrum, a promising ingredient for humans and animals—Properties, processing technologies, and uses by Costa, A., Sneddon, N.W., Goi, A., Visentin, G., Mammi, L.M.E., Savarino, E.V., Zingone, F., Formigoni, A., Penasa, M., De Marchi, M.

“…Mammalian colostrum, known as “liquid gold,” is considered a valuable source of essential nutrients, growth factors, probiotics, prebiotics, antibodies, and…”
Get full text

Myocarditis and inflammatory bowel diseases: A single-center experience and a systematic literature review by Giordani, A.S., Candelora, A., Fiacca, M., Cheng, C., Barberio, B., Baritussio, A., Marcolongo, R., Iliceto, S., Carturan, E., De Gaspari, M., Rizzo, S., Basso, C., Tarantini, G., Savarino, E.V., ALP, Caforio

“…Myocarditis and inflammatory bowel diseases (IBD) are rare conditions, but may coexist. Myocarditis in IBD may be infective, immune-mediated, or due to…”
Get full text

Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD by Martinucci, I., Savarino, E. V., Pandolfino, J. E., Russo, S., Bellini, M., Tolone, S., Tutuian, R., Roman, S., Furnari, M., Frazzoni, M., Macchia, L., Savarino, V., Marchi, S., Bortoli, N.

“…Background Multiple rapid swallowing (MRS) during high‐resolution manometry (HRM) is increasingly utilized as provocative test to assess esophageal peristaltic…”
Get full text

The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor‐responsive oesophageal eosinophilia is a GERD‐related phenomenon by Savarino, E. V., Tolone, S., Bartolo, O., de Cassan, C., Caccaro, R., Galeazzi, F., Nicoletti, L., Salvador, R., Martinato, M., Costantini, M., Savarino, V.

“…Summary Background Little is known about the relationship between proton pump inhibitor‐responsive oesophageal eosinophilia (PPI‐REE), eosinophilic esophagitis…”
Get full text

Inflammatory bowel diseases and spondyloarthritis: a focus on female patients by Caranfil, C, Lorenzon, G, Barberio, B, Ramonda, R, Savarino, E V, Zingone, F

“…Ulcerative colitis and Crohn's disease are chronic inflammatory diseases and represent the two most important types of inflammatory bowel diseases (IBD), while…”
Get full text

Multidisciplinary management of gastroesophageal reflux disease: an italian retrospective study by Nasi, G, Brandimarte, G, Pasta, A, Pellizzaro, F, Marabotto, E, Calabrese, F, Formisano, E, Manes, G, Gravina, A G, Savarino, E V

“…Abstract Background Millions of individuals are affected by gastroesophageal reflux disease (GERD) that causes significant discomfort negatively affecting…”
Get full text

P810 Association between Ustekinumab Trough Levels, Serum IL-22 and Oncostatin M Levels with Clinical and Biochemical Outcomes in Patients With Crohn’s Disease by Bertin, L, Gubbiotti, A, Buda, A, Zingone, F, Savarino, E V, Barberio, B

“…Abstract Background Ustekinumab is an effective treatment for patients with Crohn’s disease (CD). Strategies to monitor response to therapy may improve…”
Get full text

P859 Sodium Butyrate supplementation significantly improved clinical outcomes and quality of life in patients with Crohn’s Disease – results from a randomized placebo-controlled study by Facchin, S, Calgaro, M, Pandolfo, M, De Barba, C, Barberio, B, Zingone, F, Vitulo, N, Savarino, E V

“…Abstract Background Butyrate has shown anti-inflammatory effects and plays an important role in maintaining gut homeostasis, providing symptomatic relief when…”
Get full text

N005 Specialist nursing interventions for inflammatory bowel disease by Schirato, E, Savarino, E V, Martinato, M

“…Abstract Background Specialist nurses are recognised to play a key role in the management and care of patients with inflammatory bowel disease (IBD). However,…”
Get full text

N012 Nursing interventions for fatigue in IBD: A systematic literature review by Boffo, E, Savarino, E V, Martinato, M

“…Abstract Background Inflammatory bowel disease (IBD) can lead to severe and debilitating fatigue which may largely impair the health-related quality of life…”
Get full text

P542 Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis by Cingolani, L, Barberio, B, Zelante, A, Ribaldone, D, Testa, G, Bertani, L, Buda, A, Zingone, F, Savarino, E V

“…Abstract Background Tofacitinib is a small oral molecule approved to treat moderate to severe ulcerative colitis (UC), which effectiveness and safety is still…”
Get full text

P566 Colitis due to immunotherapy with anti-PD-1: a case series by De Ruvo, M, Barberio, B, Zingone, F, Bonanno, L, Dal Maso, A, Stefano, F, Chiarion Sileni, V, Savarino, E V

“…Abstract Background Anti-programmed death-1 (PD-1) drugs have been associated with immune-mediated gastrointestinal adverse events in 0.5-9% of the cases. The…”
Get full text

P714 Immunogenicity and safety of adjuvated recombinant zoster vaccine in IBD patients on different immunosuppressive therapies by Franco, M, De Bona, M, Brun, P, Bortoluzzi, M, Nappo, A, Zaetta, D, Roncen, E, Riguccio, G, Boito, C, Piselli, P, Castagliuolo, I, Savarino, E V, Buda, A

“…Abstract Background Aberrant immune regulation and the use of immunosuppressive therapy make IBD patients more susceptible to complications of primary…”
Get full text

N47 Spiritual needs of patients with IBD: preliminary results of a pilot study by Starnella, G, Rosato, I, Canova, C, Savarino, E V, Zingone, F, Barberio, B, Lorenzon, G, Gregori, D, Comoretto, R I, Martinato, M

“…Abstract Background Inflammatory bowel disease (IBD) includes Crohn's Disease (CD) and Ulcerative Colitis (UC), and both lead to manifestations that affect the…”
Get full text

P965 Ulcerative proctitis treated with biologics: is it too hard to treat? by Bertani, L, Tricò, D, Barberio, B, Bretto, E, Ceccarelli, L, Calabrese, F, Pasta, A, Bertin, L, Fabiana, Z, Maniero, D, Frara, S, De Bernardi, A, Bodini, G, Ribaldone, D G, Costa, F, Savarino, E V

“…Abstract Background Patients with ulcerative proctitis are widely considered a challenging population because the reported reduced response rate to…”
Get full text

P576 Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy by Bertani, L, Tricò, D, Barberio, B, Vernero, M, Bretto, E, Ceccarelli, L, Pardi, V, Calabrese, F, Pasta, A, Bertin, L, Fabiana, Z, Semprucci, G, Bodini, G, Ribaldone, D G, Savarino, E V, Costa, F

“…Abstract Background Ustekinumab (UST) is one of the most used biologic drugs for the treatment of Crohn’s Disease (CD) and Ulcerative Colitis (UC). However,…”
Get full text

P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series by Holvoet, T, Verstockt, B, Lenfant, M, Julsgaard, M, Drobne, D, Thakor, A, Gordon, H, Molnar, T, Savarino, E V, Ribaldone, D G, Miheller, P, Vieujean, S, Candel, I, Menchen, L, Bettenworth, D, Eder, P, Issachar, A, Lobaton, T

“…Abstract Background Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease often necessitating liver transplantation (LTX)…”
Get full text

P216 Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing) by Lorenzon, G, Marsilio, I, Maniero, D, Rigo, A, Barberio, B, Zingone, F, Bahur, B, Bray, K R, Savarino, E V

“…Abstract Background C-reactive protein (CRP) is widely used as a biomarker of inflammatory disease activity in hospitalized and non-hospitalized patients. In…”
Get full text